Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent Sciatic Block in TKA
NCT01843153Phase 4Completed
- Sponsor
- Kreiskrankenhaus Dormagen
- Start
- Apr 2013
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Kreiskrankenhaus Dormagen. Primary endpoint: pain score (VRS) at 4 days. Started Apr 2013; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01843153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843153.